Status:
COMPLETED
Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients
Lead Sponsor:
Sohag University
Conditions:
Covid19
Eligibility:
All Genders
16-90 years
Brief Summary
The objective of this study is to detect the evidence on the immune response following acute SARS-CoV-2 infections. the study will report the profile of IgG specific antibodies levels to SARS-CoV-2 in...
Detailed Description
A total of 30 COVID-19 patients for the study will be enrolled. All the patients enrolled were confirmed to be infected with SARS-CoV-2 by RT-PCR assay for nasal and pharyngeal swab specimens. For th...
Eligibility Criteria
Inclusion
- patients with recent COVID- 19 infection(2 weeks after the second negative RT-PCR assay)
Exclusion
- patients on immune-suppressive therapy
- patients with immunological disease
Key Trial Info
Start Date :
July 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 25 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04483622
Start Date
July 12 2020
End Date
December 25 2021
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospital
Sohag, Egypt